BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7677341)

  • 1. Molecular and physiological properties of clonidine-displacing substance.
    Atlas D
    Ann N Y Acad Sci; 1995 Jul; 763():314-24. PubMed ID: 7677341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and alpha-2 adrenergic receptors.
    Piletz JE; Chikkala DN; Ernsberger P
    J Pharmacol Exp Ther; 1995 Feb; 272(2):581-7. PubMed ID: 7853171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous ligands of imidazoline receptors: classic and immunoreactive clonidine-displacing substance and agmatine.
    Reis DJ; Li G; Regunathan S
    Ann N Y Acad Sci; 1995 Jul; 763():295-313. PubMed ID: 7677340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agmatine: an endogenous clonidine-displacing substance in the brain.
    Li G; Regunathan S; Barrow CJ; Eshraghi J; Cooper R; Reis DJ
    Science; 1994 Feb; 263(5149):966-9. PubMed ID: 7906055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is imidazoline site a unique receptor? A correlation with clonidine-displacing substance activity.
    Atlas D; Diamant S; Zonnenschein R
    Am J Hypertens; 1992 Apr; 5(4 Pt 2):83S-90S. PubMed ID: 1317715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imidazoline receptors and their endogenous ligands.
    Regunathan S; Reis DJ
    Annu Rev Pharmacol Toxicol; 1996; 36():511-44. PubMed ID: 8725400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An endogenous clonidine-displacing substance from bovine brain: receptor binding and hypotensive actions in the ventrolateral medulla.
    Meeley MP; Ernsberger PR; Granata AR; Reis DJ
    Life Sci; 1986 Mar; 38(12):1119-26. PubMed ID: 3007903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular responses to agmatine, a clonidine-displacing substance, in anesthetized rat.
    Sun MK; Regunathan S; Reis DJ
    Clin Exp Hypertens; 1995; 17(1-2):115-28. PubMed ID: 7735262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agmatine--a novel endogenous ligand of imidazoline receptors.
    Herman ZS
    Pol J Pharmacol; 1997; 49(2-3):85-8. PubMed ID: 9437754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonidine-displacing substance and its putative role in control of insulin secretion: a minireview.
    Chan SL
    Gen Pharmacol; 1998 Oct; 31(4):525-9. PubMed ID: 9792210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agmatine, an endogenous ligand at imidazoline binding sites, does not antagonize the clonidine-mediated blood pressure reaction.
    Raasch W; Schäfer U; Qadri F; Dominiak P
    Br J Pharmacol; 2002 Feb; 135(3):663-72. PubMed ID: 11834614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the interaction of agmatine and crude methanolic extracts of bovine lung and brain with alpha 2-adrenoceptor binding sites.
    Pinthong D; Hussain JF; Kendall DA; Wilson VG
    Br J Pharmacol; 1995 Jun; 115(4):689-95. PubMed ID: 7582492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of RP-HPLC pure clonidine-displacing substance from NG108-15 cells.
    Parker CA; Hudson AL; Nutt DJ; Dillon MP; Eglen RM; Crosby J
    Eur J Pharmacol; 2000 Jan; 387(1):27-30. PubMed ID: 10633156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonadrenergic imidazoline binding sites on human platelets.
    Piletz JE; Sletten K
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1493-502. PubMed ID: 8263811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of the putative endogenous imidazoline receptor ligand, clonidine-displacing substance, on insulin secretion from rat and human islets of Langerhans.
    Chan SL; Atlas D; James RF; Morgan NG
    Br J Pharmacol; 1997 Mar; 120(5):926-32. PubMed ID: 9138700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extraction of active clonidine-displacing substance from bovine lung and comparison with clonidine-displacing substance extracted from other tissues.
    Parker CA; Hudson AL; Nutt DJ; Dillon MP; Eglen RM; Chan SL; Morgan NG; Crosby J
    Eur J Pharmacol; 1999 Aug; 378(2):213-21. PubMed ID: 10478634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An antiserum to idazoxan recognizes an immunoreactive substance in human serum and cerebral spinal fluid which is not agmatine.
    Wang H; Regunathan S; McGowan D; Bramwell S; Reis DJ
    Neurochem Int; 1997 Jan; 30(1):85-94. PubMed ID: 9116591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An endogenous brain substance, CDS (clonidine-displacing-substance), inhibits the twitch response of rat vas deferens.
    Diamant S; Atlas D
    Biochem Biophys Res Commun; 1986 Jan; 134(1):184-90. PubMed ID: 3004427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of agmatine (clonidine-displacing substance) by diamine oxidase and the possible implications for studies of imidazoline receptors.
    Holt A; Baker GB
    Prog Brain Res; 1995; 106():187-97. PubMed ID: 8584654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harmane and harmalan are bioactive components of classical clonidine-displacing substance.
    Parker CA; Anderson NJ; Robinson ES; Price R; Tyacke RJ; Husbands SM; Dillon MP; Eglen RM; Hudson AL; Nutt DJ; Crump MP; Crosby J
    Biochemistry; 2004 Dec; 43(51):16385-92. PubMed ID: 15610033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.